(Q24243050)

https://api.crossref.org/works/10.1002%2F14651858.CD006184.PUB2

Efficacy and toxicity of thromboxane synthetase inhibitor for cerebral vasospasm after subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006184.PUB2

Randomized controlled trial of acetylsalicylic acid in aneurysmal subarachnoid hemorrhage: the MASH Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006184.PUB2

Effect of a platelet-activating factor receptor antagonist, E5880, on cerebral vasospasm after aneurysmal subarachnoid hemorrhage--open clinical trial to investigate efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006184.PUB2

Effects of nonsteroidal anti-inflammatory drugs on hemostasis in patients with aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006184.PUB2

Prevention of Cerebral Ischemic Symptoms in Cerebral Vasospasm with Trapidil, an Antagonist and Selective Synthesis Inhibitor of Thromboxane A2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006184.PUB2

Epidemiology of Aneurysmal Subarachnoid Hemorrhage in Australia and New Zealand

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006184.PUB2

Rebleeding, secondary ischemia, and timing of operation in patients with subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006184.PUB2

Cerebral arterial spasm--a clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006184.PUB2

Decrease in platelet count as an independent risk factor for symptomatic vasospasm following aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006184.PUB2

Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006184.PUB2

Platelet thromboxane release and delayed cerebral ischemia in patients with subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006184.PUB2

Impairment of anti-platelet-aggregating activity of endothelial cells after experimental subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006184.PUB2

Aspirin as an antiplatelet drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006184.PUB2

Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006184.PUB2

Calcium antagonists for aneurysmal subarachnoid haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006184.PUB2

Complications and outcome in patients with aneurysmal subarachnoid haemorrhage: a prospective hospital based cohort study in the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006184.PUB2

Influence of aspirin on outcome following aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006184.PUB2

Study design and outcome measures in studies on aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006184.PUB2

The mechanism of action of aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006184.PUB2

Adverse effects and drug interactions of antithrombotic agents used in prevention of ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006184.PUB2

Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006184.PUB2

Preventive therapy against delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage: trials of thromboxane A2 synthetase inhibitor and hyperdynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006184.PUB2

7 January 2021

Double-blind trial of aspirin in patient receiving tranexamic acid for subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006184.PUB2

7 January 2021

Prevention of cerebral vasospasm with OKY-046 an imidazole derivative and a thromboxane synthetase inhibitor. A preliminary co-operative clinical study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006184.PUB2

7 January 2021

Clinical study of OKY-046, a thromboxane synthetase inhibitor, in prevention of cerebral vasospasms and delayed cerebral ischaemic symptoms after subarachnoid haemorrhage due to aneurysmal rupture: a randomized double-blind study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006184.PUB2

7 January 2021

Thromboxane B2 levels in serum during continuous administration of nimodipine to patients with aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006184.PUB2

7 January 2021

Role of platelet function in symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006184.PUB2

7 January 2021

Randomized pilot trial of postoperative aspirin in subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006184.PUB2

7 January 2021

Comparison of intimal platelet accumulation in cerebral arteries in two experimental models of subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006184.PUB2

7 January 2021

Effect of selective inhibitor of thromboxane A2 synthetase on cerebral vasospasm after early surgery

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006184.PUB2

7 January 2021

Aspirin and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006184.PUB2

7 January 2021

10.1002/14651858.CD006184.PUB2

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ltqglexcerg5lg7yp4i7xqxely

30 July 2022

release_ltqglexcerg5lg7yp4i7xqxely

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ltqglexcerg5lg7yp4i7xqxely

30 July 2022

https://api.fatcat.wiki/v0/release/ltqglexcerg5lg7yp4i7xqxely

1 reference

30 July 2022

https://api.fatcat.wiki/v0/release/ltqglexcerg5lg7yp4i7xqxely

1 reference

30 July 2022